Hollebecque, F.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

101

Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours

Hollebecque, A., Bahleda, R., Faivre, L., Adam, J., Poinsignon, V., Paci, A., Gomez-Roca, C., Thery, J.C., Le Deley, M.C., Varga, A., Gazzah, A., Ileana, E., Gharib, M., Angevin, E., Malekzadeh, K., M

Journal:

European Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 644 KB

english, 2017

102

Identification of new prognostic factors in phase I patients treated by immunotherapy

Bigot, F., Alvarez, E. Castanon, Hollebecque, A., Carmona, A., Postel-Vinay, S., Angevin, E., Armand, J-P., Ribrag, V., Aspeslagh, S., Varga, A., Bahleda, R., Gazzah, A., Bonnet, C., Michot, J-M., Mar

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 36 KB

english, 2016

103

Matching genomic molecular aberrations with molecular targeted agents: Are biliary tract cancers an ideal playground?

Verlingue, Loic, Hollebecque, Antoine, Boige, Valérie, Ducreux, Michel, Malka, David, Ferté, Charles

Journal:

European Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 1.22 MB

english, 2017

104

Patient-reported tolerability of adverse events in phase 1 trials

Henon, Clémence, Lissa, Delphine, Paoletti, Xavier, Thibault, Constance, Tourneau, Christophe Le, Lanoy, Emilie, Hollebecque, Antoine, Massard, Christophe, Soria, Jean-Charles, Postel-Vinay, Sophie

Journal:

Year:

2017

Language:

english

File:

PDF, 1.82 MB

english, 2017

105

Clinical efficacy of HER3 partners' inhibitors in ERBB3 mutated cancer patients

Verlingue, L., Massard, C., Hollebecque, A., Alvarez, E. Castanon, Postel-Vinay, S., Angevin, E., Armand, J-P., Aspeslagh, S., Varga, A., Ratislav, B., Gazzah, A., Michot, J-M., Lacroix, L., De Baere,

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 37 KB

english, 2016

106

First-in-human phase I study of oral S49076, a unique MET/AXL/FGFR inhibitor, in advanced solid tumours

Rodon, Jordi, Postel-Vinay, Sophie, Hollebecque, Antoine, Nuciforo, Paolo, Azaro, Analia, Cattan, Valérie, Marfai, Lucie, Sudey, Isabelle, Brendel, Karl, Delmas, Audrey, Malasse, Stéphanie, Soria, Jea

Journal:

European Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 1.54 MB

english, 2017

107

Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas

Aspeslagh, Sandrine, Stein, Mark, Bahleda, Rastilav, Hollebecque, Antoine, Salles, Gilles, Gyan, Emmanuel, Fudio, Salvador, Extremera, Sonia, Alfaro, Vicente, Soto-Matos, Arturo, Soria, Jean-Charles

Journal:

Anti-Cancer Drugs

Year:

2017

Language:

english

File:

PDF, 200 KB

english, 2017

108

Angiogenesis inhibition in the second-line treatment of metastatic colorectal cancer: A systematic review and pooled analysis

Chebib, Ralph, Verlingue, Loic, Cozic, Nathalie, Faron, Matthieu, Burtin, Pascal, Boige, Valérie, Hollebecque, Antoine, Malka, David

Journal:

Seminars in Oncology

Year:

2017

Language:

english

File:

PDF, 1.42 MB

english, 2017

109

Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)

Bigot, Frédéric, Castanon, Eduardo, Baldini, Capucine, Hollebecque, Antoine, Carmona, Alberto, Postel-Vinay, Sophie, Angevin, Eric, Armand, Jean-Pierre, Ribrag, Vincent, Aspeslagh, Sandrine, Varga, An

Journal:

European Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 535 KB

english, 2017

110

Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors)

Sun, Roger, Champiat, Stéphane, Dercle, Laurent, Aspeslagh, Sandrine, Castanon, Eduardo, Limkin, Elaine Johanna, Baldini, Capucine, Postel-Vinay, Sophie, Hollebecque, Antoine, Massard, Christophe, Amm

Journal:

European Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 438 KB

english, 2017

111

Conversion to Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma After Bidirectional Chemotherapy

Le Roy, Florence, Gelli, Maximiliano, Hollebecque, Antoine, Honoré, Charles, Boige, Valerie, Dartigues, Peggy, Benhaim, Leonor, Malka, David, Ducreux, Michel, Elias, Dominique, Goéré, Diane

Journal:

Annals of Surgical Oncology

Year:

2017

Language:

english

File:

PDF, 524 KB

english, 2017

112

Clinical Relevance Of Alternative Endpoints In Colorectal Cancer First Line Therapy With Bevacizumab: A Retrospective Study

Turpin, A., Paget-Bailly, S., Ploquin, A., Hollebecque, A., Peugniez, C., El-Hajbi, F., Bonnetain, F., Hebbar, M.

Journal:

Clinical Colorectal Cancer

Year:

2017

Language:

english

File:

PDF, 1.58 MB

english, 2017

113

Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis

Sakr, Riwa, Renneville, Aline, Saada, Veronique, Cotteret, Sophie, Martin, Jean-Edouard, Droin, Nathalie, Selimoglu-Buet, Dorothée, Besse, Benjamin, Hollebecque, Antoine, Marzac, Christophe, Pasquier,

Journal:

Leukemia and Lymphoma

Year:

2017

Language:

english

File:

PDF, 736 KB

english, 2017

114

A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification

Angevin, Eric, Spitaleri, Gianluca, Rodon, Jordi, Dotti, Katia, Isambert, Nicolas, Salvagni, Stefania, Moreno, Victor, Assadourian, Sylvie, Gomez, Corinne, Harnois, Marzia, Hollebecque, Antoine, Azaro

Journal:

European Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 470 KB

english, 2017

115

365OPhase 1 safety and clinical activity of BLU-554 in advanced hepatocellular carcinoma (HCC)

Kim, R., Sarker, D., Macarulla, T., Yau, T., Choo, S.P., Meyer, T., Hollebecque, A., Whisenant, J., Sung, M., Yoon, J-H., Lim, H.Y., Zhu, A., Park, J-W., Faivre, S., Mazzaferro, V., Shi, H., Schmidt-K

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 72 KB

english, 2017

116

An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma

Temam, S, Spicer, J, Farzaneh, F, Soria, J C, Oppenheim, D, McGurk, M, Hollebecque, A, Sarini, J, Hussain, K, Soehrman Brossard, S, Manenti, L, Evers, S, Delmar, P, Di Scala, L, Mancao, C, Feuerhake,

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 546 KB

english, 2017

117

1632PDA novel radiomic based imaging tool to monitor tumor lymphocyte infiltration and outcome of patients treated by anti-PD-1/PD-L1

Sun, R., Limkin, E.J., Dercle, L., Champiat, S., Reuzé, S., Brandao, D., Verlingue, L., Ammari, S., Aspeslagh, S., Schernberg, A., Postel-Vinay, S., Hollebecque, A., Massard, C., Marabelle, A., Robert

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 49 KB

english, 2017

118

Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer

Corcoran, Ryan B., Andre, Thierry, Atreya, Chloe E., Schellens, Jan H.M., Yoshino, Takayuki, Bendell, Johanna C., Hollebecque, Antoine, McRee, Autumn J., Siena, Salvatore, Middleton, Gary, Muro, Kei,

Journal:

Cancer Discovery

Year:

2018

Language:

english

File:

PDF, 1.21 MB

english, 2018

119

Is anti-PD-1/PD-L1 immunotherapy sensitizing for conventional cancer therapies?

Matias, M., Aspeslagh, S., Palomar, V., Lanoy, E., Dercle, L., Even, C., Ferte, C., Hollebecque, A., Marabelle, A., Massard, C., Soria, J-C., Postel-Vinay, S.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 40 KB

english, 2016

120

Immunotherapy phase I trials in patients Older than 70 years with advanced solid tumours

Herin, H., Aspeslagh, S., Castanon, E., Dyevre, V., Marabelle, A., Varga, A., Postel Vinay, S., Michot, J.M., Ribrag, V., Gazzah, A., Bahleda, R., Mir, O., Massard, C., Hollebecque, A., Soria, J.C., B

Journal:

European Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 642 KB

english, 2018

121

Correlation between alternative endpoints and overall survival in metastatic colorectal cancer patients eligible to a maintenance strategy

Turpin, A., Paget-Bailly, S., Ploquin, A., Hollebecque, A., Dominguez, S., Bonnetain, F., El Hajbi, F., Hebbar, M.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 33 KB

english, 2016

122

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

Négrier, Sylvie, Pérol, David, Bahleda, Rastislav, Hollebecque, Antoine, Chatelut, Etienne, Boyle, Helen, Cassier, Philippe, Metzger, Séverine, Blanc, Ellen, Soria, Jean-Charles, Escudier, Bernard

Journal:

Year:

2017

Language:

english

File:

PDF, 713 KB

english, 2017

123

Multilayer global longitudinal strain in patients with cancer: A comparison of two vendors

Ancedy, Yann, Ederhy, Stephane, Lang, Sylvie, Hollebecque, Antoine, Dufour, Laurie Soulat, Adavane-Scheuble, Saroumadi, Etienney, Arnaud, Chauvet, Marion, Soria, Jean Charles, Cohen, Ariel

Journal:

Archives of Cardiovascular Diseases

Year:

2018

File:

PDF, 2.16 MB

2018

124

Organisational factors influencing early clinical trials enrollment: Gustave Roussy experience

Besle, Sylvain, Schultz, Emilien, Hollebecque, Antoine, Varga, Andreea, Baldini, Capucine, Martin, Patricia, Postel-Vinay, Sophie, Bahleda, Rastislav, Gazzah, Anas, Michot, Jean-Marie, Marabelle, Auré

Journal:

European Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 768 KB

english, 2018

125

1634PFGFR pathway genomic aberrations and response to FGFRs inhibitors

Faure, M., Hollebecque, A., Bahleda, R., Soria, J-C., Dyevre, V.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 51 KB

english, 2017

126

1163PImmunotherapy phase I trials in patients over 70 years with advanced solid tumours: The Gustave Roussy experience

Herin, H., Castanon, E., Dyevre, V., Aspeslagh, S., Marabelle, A., Postel-Vinay, S., Varga, A., Gazzah, A., Ribrag, V., Bahleda, R., Michot, J-M., Mir, O., Massard, C., Hollebecque, A., Soria, J-C., B

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 45 KB

english, 2017

127

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity

Bibault, Jean-Emmanuel, Dewas, Sylvain, Vautravers-Dewas, Claire, Hollebecque, Antoine, Jarraya, Hajer, Lacornerie, Thomas, Lartigau, Eric, Mirabel, Xavier, Villa, Erica

Journal:

Year:

2013

Language:

english

File:

PDF, 268 KB

english, 2013

128

A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials

Kempf, Emmanuelle, Lemoine, Nathalie, Tergemina-Clain, Gabrielle, Turpin, Anthony, Postel-Vinay, Sophie, Lanoy, Emilie, Soria, Jean-Charles, Massard, Christophe, Hollebecque, Antoine, Alonso, Marta M.

Journal:

Year:

2016

Language:

english

File:

PDF, 152 KB

english, 2016

129

Outcomes of long-term responders to anti-programmed death 1 and anti-programmed death ligand 1 when being rechallenged with the same anti-programmed death 1 and anti-programmed death ligand 1 at progression

Bernard-Tessier, A., Baldini, C., Martin, Patricia, Champiat, Stéphane, Hollebecque, Antoine, Postel-Vinay, Sophie, Varga, Andrea, Bahleda, Rastilav, Gazzah, Anas, Michot, Jean-Marie, Ribrag, Vincent,

Journal:

European Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 401 KB

english, 2018

130

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

Sun, Roger, Limkin, Elaine Johanna, Vakalopoulou, Maria, Dercle, Laurent, Champiat, Stéphane, Han, Shan Rong, Verlingue, Loïc, Brandao, David, Lancia, Andrea, Ammari, Samy, Hollebecque, Antoine, Scoaz

Journal:

The Lancet Oncology

Year:

2018

Language:

english

File:

PDF, 1.70 MB

english, 2018

131

Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF -mutant ganglioglioma

Touat, Mehdi, Gratieux, Julie, Condette Auliac, Stephanie, Sejean, Karine, Aldea, Sorin, Savatovsky, Julien, Perkins, Géraldine, Blons, Hélène, Ligon, Keith L., Idbaih, Ahmed, Hollebecque, Antoine, Gi

Journal:

Year:

2018

Language:

english

File:

PDF, 439 KB

english, 2018

132

1703PDLandscape of DNA damage response (DDR) genes alterations in the prospective MOSCATO and MATCH R trials

El Dakdouki, Y., Verlingue, L., Massard, C., Bahleda, R., Hollebecque, A., Mahjoubi, L., Rouleau, E., Lacroix, L., Auger, N., Scoazec, J-Y., Solary, E., Marabelle, A., André, F., Soria, J-C., Postel-V

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 78 KB

english, 2017

133

Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks?

Prud'homme, Clara, Deschamps, Fréderic, Allorant, Adrien, Massard, Christophe, Hollebecque, Antoine, Yevich, Steve, Ngo-Camus, Maud, Gravel, Guillaume, Nicotra, Claudio, Michiels, Stefan, Scoazec, Jea

Journal:

European Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 446 KB

english, 2018

134

Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?

Watson, Sarah, Menis, Jessica, Baldini, Capucine, Martin-Romano, Patricia, Michot, Jean-Marie, Hollebecque, Antoine, Armand, Jean-Pierre, Massard, Christophe, Soria, Jean-Charles, Postel-Vinay, Sophie

Journal:

British Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 274 KB

english, 2018

135

756PInterim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations

Hollebecque, A, Borad, M, Sahai, V, Catenacci, D V T, Murphy, A, Vaccaro, G, Paulson, A, Oh, D-Y, Féliz, L, Lihou, C, Zhen, H, Abou-Alfa, G K

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 79 KB

english, 2018

136

Systemic treatment of pancreatic cancer revisited

Ducreux, Michel, Seufferlein, Thomas, Van Laethem, Jean-Luc, Laurent-Puig, Pierre, Smolenschi, Cristina, Malka, David, Boige, Valérie, Hollebecque, Antoine, Conroy, Thierry

Journal:

Seminars in Oncology

Year:

2018

Language:

english

File:

PDF, 902 KB

english, 2018

137

1832PDPhase I study of CC-90011 in patients with advanced solid tumors and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)

Hollebecque, A, de Bono, J, Plummer, R, Isambert, N, Martin-Romano, P, Baudin, E, Mora, S, Harding, A, Nguyen, A, Filvaroff, E, Lamba, M, Liu, K, De Alvaro, J, DiMartino, J, Zuraek, M, Nikolova, Z

Journal:

Annals of Oncology

Year:

2018

File:

PDF, 107 KB

2018

138

470PSafety run-in evaluation of the phase I trial of trifluridine/tipiracil (FTD/TPI) in combination with oxaliplatin and a monoclonal antibody (bevacizumab or nivolumab) in patients (pts) with metastatic colorectal cancer (mCRC)

Calvo Ferrandiz, A, Dahan, L, Hollebecque, A, Prager, G, Andre, T, Argiles Martinez, G, Bordonaro, R, Stein, A, Tortora, G, Leger, C, Amellal, N, Tabernero, J

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 91 KB

english, 2018

139

Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer

Simonaggio, Audrey, Michot, Jean Marie, Voisin, Anne Laure, Le Pavec, Jérome, Collins, Michael, Lallart, Audrey, Cengizalp, Geoffray, Vozy, Aurore, Laparra, Ariane, Varga, Andréa, Hollebecque, Antoine

Journal:

Year:

2019

Language:

english

File:

PDF, 229 KB

english, 2019

140

Molecular targeted therapy of BRAF -mutant colorectal cancer

Ducreux, Michel, Chamseddine, Ali, Laurent-Puig, Pierre, Smolenschi, Cristina, Hollebecque, Antoine, Dartigues, Peggy, Samallin, Emmanuelle, Boige, Valérie, Malka, David, Gelli, Maximiliano

Journal:

Therapeutic Advances in Medical Oncology

Year:

2019

Language:

english

File:

PDF, 355 KB

english, 2019

141

Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study

Lowery, Maeve A, Burris, Howard A, Janku, Filip, Shroff, Rachna T, Cleary, James M, Azad, Nilofer S, Goyal, Lipika, Maher, Elizabeth A, Gore, Lia, Hollebecque, Antoine, Beeram, Muralidhar, Trent, Jona

Journal:

The Lancet Gastroenterology & Hepatology

Year:

2019

Language:

english

File:

PDF, 628 KB

english, 2019

142

Efficacy of Vemurafenib in Patients With Non–Small-Cell Lung Cancer With BRAF V600 Mutation: An Open-Label, Single-Arm Cohort of the Histology-Independent VE-BASKET Study

Subbiah, Vivek, Gervais, Radj, Riely, Gregory, Hollebecque, Antoine, Blay, Jean-Yves, Felip, Enriqueta, Schuler, Martin, Gonçalves, Anthony, Italiano, Antonio, Keedy, Vicki, Chau, Ian, Puzanov, Igor,

Journal:

JCO Precision Oncology

Year:

2019

Language:

english

File:

PDF, 784 KB

english, 2019

143

Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer

Mohan, Sumitra, Ayub, Mahmood, Rothwell, Dominic G., Gulati, Sakshi, Kilerci, Bedirhan, Hollebecque, Antoine, Sun Leong, Hui, Smith, Nigel K., Sahoo, Sudhakar, Descamps, Tine, Zhou, Cong, Hubner, Rich

Journal:

Scientific Reports

Year:

2019

Language:

english

File:

PDF, 938 KB

english, 2019

144

Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring BRAF V600 Mutations: A Cohort of the Histology-Independent VE-BASKET Study

Raje, Noopur, Chau, Ian, Hyman, David M., Ribrag, Vincent, Blay, Jean-Yves, Tabernero, Josep, Elez, Elena, Wolf, Jürgen, Yee, Andrew J., Kaiser, Martin, Landau, Heather, Michot, Jean-Marie, Hollebecqu

Journal:

JCO Precision Oncology

Year:

2018

Language:

english

File:

PDF, 739 KB

english, 2018

145

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

Naumann, R. Wendel, Hollebecque, Antoine, Meyer, Tim, Devlin, Michael-John, Oaknin, Ana, Kerger, Joseph, López-Picazo, Jose M., Machiels, Jean-Pascal, Delord, Jean-Pierre, Evans, Thomas R.J., Boni, Va

Journal:

Journal of Clinical Oncology

Year:

2019

Language:

english

File:

PDF, 1.11 MB

english, 2019

146

Facts and new hopes on selective FGFR inhibitors in solid tumors

Facchinetti, Francesco, Hollebecque, Antoine, Bahleda, Rastilav, Loriot, Yohann, Olaussen, Ken A, Massard, Christophe, Friboulet, Luc

Journal:

Clinical Cancer Research

Year:

2019

Language:

english

File:

PDF, 19.51 MB

english, 2019

147

1220PPhase I study evaluating safety, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of ABBV-428, first-in-class mesothelin (MSLN)-CD40 bispecific, in patients (pts) with advanced solid tumours

Luke, J J, Fong, L, Chung, K, Tolcher, A W, Kelly, K, Hollebecque, A, Le Tourneau, C, Subbiah, V, Tsai, F, Kao, S, Cassier, P, Khasraw, M, Allaire, K, Fan, F, Fang, H, Patel, M, Henner, W, Hayflick, J

Journal:

Annals of Oncology

Year:

2019

Language:

english

File:

PDF, 87 KB

english, 2019

148

Facts and new hopes on selective FGFR inhibitors in solid tumors

Facchinetti, Francesco, Hollebecque, Antoine, Bahleda, Rastilav, Loriot, Yohann, Olaussen, Ken A, Massard, Christophe, Friboulet, Luc

Journal:

Clinical Cancer Research

Year:

2019

File:

PDF, 19.51 MB

2019

149

LBA40FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)

Vogel, A, Sahai, V, Hollebecque, A, Vaccaro, G, Melisi, D, Al-Rajabi, R, Paulson, A S, Borad, M J, Gallinson, D, Murphy, A G, Oh, D-Y, Dotan, E, Catenacci, D V, Van Cutsem, E, Lihou, C F, Zhen, H, Fél

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 78 KB

2019

150

A Phase 1 Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer

Sullivan, Ryan J., Hollebecque, Antoine, Flaherty, Keith T, Shapiro, Geoffrey I., Rodon Ahnert, Jordi, Millward, Michael J., Zhang, Wei, Gao, Ling, Sykes, Amanda, Willard, Melinda D, Yu, Danni, Schade

Journal:

Molecular Cancer Therapeutics

Year:

2019

Language:

english

File:

PDF, 1.94 MB

english, 2019